lopment, manufacturing and other activities, the conduct, timing and results of pre-clinical and clinical studies of the Company???s product candidates, the adequacy of capital resources and the availability of additional funding, and other factors detailed in the Company???s public filings with the U.S. Securities and Exchange Commission.